Health / Medical Topics |
Amsterdam Criteria
Research criteria established for defining Hereditary Non-Polyposis Colorectal Cancer (HNPCC) families as established by the International Collaborative Group (ICG) meeting in Amsterdam in 1990: 1. One member diagnosed with colorectal cancer before age 50; 2. Two affected generations; 3. Three affected relatives, 1 of them a first-degree relative of the other 2; 4. Familial adenomatous polyposis should be excluded; 5. Tumors should be verified by pathological examination. (NCI Thesaurus)
YOU MAY ALSO LIKE
A retinobenzoic acid with potential antineoplastic activity. Amsilarotene inhibits retinoblastoma-gene product (RB) phosphorylation and increases the presence of 2 cyclin-dependent kinase (CDK)…
Cytokine-mediated signal transduction in the JAK-STAT cascade requires the involvement of adaptor molecules. One such signal-transducing adaptor molecule contains an SH3 domain…
The lactate form of amsacrine, an aminoacridine analog and topoisomerase II inhibitor, with antineoplastic activity. Although the exact relationship between DNA binding…
An anticancer drug that belongs to the family of drugs called topoisomerase inhibitors.
The hydrochloride salt of a third-generation synthetic 9-amino-anthracycline with antineoplastic activity. Amrubicin intercalates into DNA and inhibits the activity of topoisomerase II,…
A substance being studied in the treatment of lung cancer. It is a type of anthracycline analog.